Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension

Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension

Mi-Seung Shin,1 Dae Ryong Kang,2 Changsoo Kim,3 Eun Joo Cho,4 Ki-Chul Sung,5 Seok-Min Kang,6 Dong-Soo Kim,7 Seung Jae Joo,8 Seung Hwan Lee,9 Kyung-Kuk Hwang,10 Jeong Bae Park11 1Division of Cardiology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, 2Office of Biosta...

Full description

Bibliographic Details
Main Authors:	Shin MS, Kang DR, Kim C, Cho EJ, Sung KC, Kang SM, Kim DS, Joo SJ, Lee SH, Hwang KK, Park JB
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-05-01
Series:	Drug Design, Development and Therapy
Subjects:	Fimasartan Hypertension Blood pressure variability
Online Access:	https://www.dovepress.com/fimasartan-for-independent-reduction-of-blood-pressure-variability-in--peer-reviewed-article-DDDT

Similar Items

Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
by: Kang WY, et al.
Published: (2018-10-01)

A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
by: Kang WY, et al.
Published: (2020-05-01)

Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trial
by: Min-gu Kang, et al.
Published: (2019-07-01)

The influence of dietary sodium content on the pharmacokinetics and pharmacodynamics of fimasartan
by: Gu N, et al.
Published: (2016-04-01)

Fimasartan: A new armament to fight hypertension
by: Akshyaya Pradhan, et al.
Published: (2019-01-01)

Clinical characteristics and satisfaction with the fimasartan in Korean hypertensive patients: a prospective, cross-sectional and open-label, 8-week switching study (Kanarb-hypertension epidemiology medication satisfaction study; K-HEMS study)
by: Dong Joo Oh, et al.
Published: (2018-09-01)

Evaluation of stability and simultaneous determination of fimasartan and amlodipine by a HPLC method in combination tablets
by: Hyeon Woo Moon, et al.
Published: (2014-06-01)

A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy
by: Eun-Seok Jeon, et al.
Published: (2022-12-01)

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects
by: Oh M, et al.
Published: (2018-05-01)

Long-Term Safety of a Novel Angiotensin Receptor Blocker, Fimasartan, According to the Absence or Presence of Underlying Liver Disease in Korean Hypertensive Patients: A Prospective, 12-Month, Observational Study
by: Oh GC, et al.
Published: (2020-04-01)

Regional Absorption of Fimasartan in the Gastrointestinal Tract by an Improved In Situ Absorption Method in Rats
by: Tae Hwan Kim, et al.
Published: (2018-10-01)

Simultaneous Analysis of a Combination of Anti-Hypertensive Drugs, Fimasartan, Amlodipine, and Hydrochlorothiazide, in Rats Using LC-MS/MS and Subsequent Application to Pharmacokinetic Drug Interaction with Red Ginseng Extract
by: So-Yeon Jeon, et al.
Published: (2022-09-01)

Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers
by: Choi Y, et al.
Published: (2018-07-01)

Comparative efficacy and safety of fimasartan in patients with hypertension: A network meta‐analysis of randomized controlled trials
by: Suk Min Seo, et al.
Published: (2022-08-01)

Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets
by: Hwang JG, et al.
Published: (2020-05-01)

Analytical method development and validation for simultaneous estimation of Fimasartan Potassium Trihydrate and Cilnidipine in synthetic mixture by HPLC for the treatment of hypertension stage-II
by: Radhika G. Sojitra, et al.
Published: (2021-09-01)

Simultaneous Estimation of Fimasartan potassium trihydrate and Atorvastatin calcium with Greenness Assessment using HPLC and UV Spectrophotometric Methods
by: Ashok H Akabari, et al.
Published: (2023-09-01)

Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy
by: Rhee MY, et al.
Published: (2015-06-01)

Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study)
by: Chung WB, et al.
Published: (2020-01-01)

Fimasartan reduces clinic and home pulse pressure in elderly hypertensive patients: A K-MetS study.
by: Eun Joo Cho, et al.
Published: (2019-01-01)

The safety and efficacy of fimasartan in Indian patients with systemic arterial hypertension
by: Pankaj Jariwala, et al.
Published: (2021-12-01)

The Ameliorative Effect of Fimasartan against Methotrexate-Induced Nephrotoxicity in Rats
by: Maryam Rasheed Abd, et al.
Published: (2022-06-01)

Effect of home blood pressure monitoring for blood pressure control in hypertensive patients taking multiple antihypertensive medications including fimasartan (the FORTE study)
by: Jung-Yeon Choi, et al.
Published: (2020-12-01)

P118 Arterial Stiffness in Patients with Arterial Hypertension on Short Term Dual Treatment with Fimasartan/Amlodipine
by: Brandon Giovany Illescas Vidrio, et al.
Published: (2020-02-01)

Gender-specific differences in the incidence of microalbuminuria in metabolic syndrome patients after treatment with fimasartan: The K-MetS study.
by: Jeong Bae Park, et al.
Published: (2017-01-01)

Factors associated with exacerbation in mild-to-moderate COPD patients
by: Kim JK, et al.
Published: (2016-06-01)

Fimasartan, an angiotensin II receptor antagonist, ameliorates an in vivo zebrafish model of heart failure
by: Hailian Quan, et al.
Published: (2020-11-01)

Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate COVID-19
by: Taeyun Kim, et al.
Published: (2022-03-01)

Poor physical fitness is independently associated with mild cognitive impairment in elderly Koreans
by: SH Lee, et al.
Published: (2016-01-01)

Use of nebivolol in patients with mild and moderate hypertensive disease
by: L V Zhigunova, et al.
Published: (2003-03-01)

Effect of Yoga and Meditation on Mild to Moderate Essential Hypertensives
by: DEEPA T., et al.
Published: (2012-02-01)

FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC): study protocol for randomized controlled trial
by: Jang-Young Kim, et al.
Published: (2017-12-01)

Predictive Variables for Sonographically Guided Corticosteroid Injection in Mild-to-Moderate Carpal Tunnel Syndrome
by: Seong Yun Chung, et al.
Published: (2018-04-01)

Prevalence of nocturnal hypoxaemia amongst men with mild to moderate hypertension.
by: Warley, A, et al.
Published: (1988)

EFFICACY AND SAFETY OF ALBAREL IN PATIENTS WITH MILD, MODERATE AND SEVERE HYPERTENSION
by: N. N. Borovkov, et al.
Published: (2003-08-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (1970-01-01)

Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study
by: Han SH, et al.
Published: (2018-12-01)

Effects of high-flow nasal cannula in patients with mild to moderate hypercapnia: a prospective observational study
by: Kyung Hun Nam, et al.
Published: (2021-08-01)

Efficacy and Safety of Laparoscopy for Mild and Moderate Pediatric Abdominal Trauma: A Systematic Review and Meta-Analysis
by: Yun Chul Park, et al.
Published: (2022-03-01)

Uncertainties: Which antihypertensive treatment is better in pregnancy for mild to moderate hypertension?
by: Ashworth, D, et al.
Published: (2022)